Skip to main content
Erschienen in: Journal of Cancer Education 2/2016

10.05.2015

Cervical Cancer Knowledge, Perceptions and Screening Behaviour Among Female University Students in Ghana

verfasst von: Charity Binka, Samuel H Nyarko, David T Doku

Erschienen in: Journal of Cancer Education | Ausgabe 2/2016

Einloggen, um Zugang zu erhalten

Abstract

Cervical cancer is becoming a leading cause of death among women in developing countries. Nevertheless, little is known regarding knowledge and perception of cervical cancer and screening behaviour particularly among female tertiary students in Ghana. This study sought to examine the knowledge and perceptions of cervical cancer and screening behaviour among female students in the University of Cape Coast and Ghana Institute of Management and Public Administration in Ghana. A cross-sectional survey design was adopted for the study. Systematic and stratified random sampling techniques were used to select 410 participants for the study. The study found that the participants lacked knowledge on specific risk factors and symptoms of cervical cancer. Also, even though the participants had a fair perception of cervical cancer, they had a poor cervical cancer screening behaviour. Awareness of cervical cancer was significantly influenced by religious affiliation while cervical cancer screening was significantly determined by the working status of the participants. Specific knowledge on cervical cancer and its risk factors as well as regular screening behaviour is paramount to the prevention of cervical cancer. Consequently, the University Health Services should focus on promoting regular cervical cancer awareness campaigns and screening among the students particularly, females.
Literatur
1.
Zurück zum Zitat International Agency for Research on Cancer [IARC] (2012) Globocan 2012: estimated cancer incidence, mortality and prevalence worldwide in 2012. http://globocan.iarc.fr /Pages/fact_sheets_cancer.aspx. (Accessed June 25, 2014) International Agency for Research on Cancer [IARC] (2012) Globocan 2012: estimated cancer incidence, mortality and prevalence worldwide in 2012. http://​globocan.​iarc.​fr /Pages/fact_sheets_cancer.aspx. (Accessed June 25, 2014)
3.
Zurück zum Zitat Anorlu RI (2008) Cervical cancer: the sub-Saharan African perspective. Reprod Health Matt 16(32):41–49CrossRef Anorlu RI (2008) Cervical cancer: the sub-Saharan African perspective. Reprod Health Matt 16(32):41–49CrossRef
4.
Zurück zum Zitat Hoque E, Hoque M (2009) Knowledge of and attitude towards cervical cancer among female university students in South Africa. S Afr J Epidem Infect 24(1):21–24 Hoque E, Hoque M (2009) Knowledge of and attitude towards cervical cancer among female university students in South Africa. S Afr J Epidem Infect 24(1):21–24
5.
Zurück zum Zitat Abotchie PN, Shokar NK (2009) Cervical cancer screening among college students in Ghana: knowledge and health beliefs. Int J Gynaecol Cancer 19(3):412–416CrossRef Abotchie PN, Shokar NK (2009) Cervical cancer screening among college students in Ghana: knowledge and health beliefs. Int J Gynaecol Cancer 19(3):412–416CrossRef
6.
Zurück zum Zitat Leung SSK, Leung I (2010) Cervical cancer screening: knowledge, health perception and attendance rate among Hong Kong Chinese women. Inter J Women Health 2:221–228CrossRef Leung SSK, Leung I (2010) Cervical cancer screening: knowledge, health perception and attendance rate among Hong Kong Chinese women. Inter J Women Health 2:221–228CrossRef
7.
Zurück zum Zitat Sudenga SL, Rositch AF, Otieno WA et al (2013) Knowledge, attitudes, practices, and perceived risk of cervical cancer among Kenyan women: brief report. Int J Gynaecol Cancer 23(5):895–899CrossRef Sudenga SL, Rositch AF, Otieno WA et al (2013) Knowledge, attitudes, practices, and perceived risk of cervical cancer among Kenyan women: brief report. Int J Gynaecol Cancer 23(5):895–899CrossRef
8.
Zurück zum Zitat Ayinde OA, Omigbodun AO, Ilesanmi AO (2004) Awareness of cervical cancer, Papanicolau’s smear and its utilisation among female undergraduates in Ibadan. Afr J Reprod Health 8:68–80CrossRefPubMed Ayinde OA, Omigbodun AO, Ilesanmi AO (2004) Awareness of cervical cancer, Papanicolau’s smear and its utilisation among female undergraduates in Ibadan. Afr J Reprod Health 8:68–80CrossRefPubMed
9.
Zurück zum Zitat Aswathy S, Quereshi MA, Kurian B et al (2012) Cervical cancer screening: current knowledge & practice among women in a rural population of Kerala, India. Ind J Med Res 136:205–210 Aswathy S, Quereshi MA, Kurian B et al (2012) Cervical cancer screening: current knowledge & practice among women in a rural population of Kerala, India. Ind J Med Res 136:205–210
10.
Zurück zum Zitat Sankaranarayanan R, Ferlay J (2006) Worldwide burden of gynaecological cancer: the size of the problem. Best Prac Res: Clin Obstet Gynaecol 20:207–225CrossRef Sankaranarayanan R, Ferlay J (2006) Worldwide burden of gynaecological cancer: the size of the problem. Best Prac Res: Clin Obstet Gynaecol 20:207–225CrossRef
12.
Zurück zum Zitat Al-Sairafi M, Mohamed FA (2009) Knowledge, attitudes, and practice related to cervical cancer screening among Kuwaiti women. Med Princ Pract 18(1):35–42CrossRefPubMed Al-Sairafi M, Mohamed FA (2009) Knowledge, attitudes, and practice related to cervical cancer screening among Kuwaiti women. Med Princ Pract 18(1):35–42CrossRefPubMed
13.
Zurück zum Zitat Al-Meer FM, Aseel MT, Al-Khalaf J et al (2011) Knowledge, attitude and practices regarding cervical cancer and screening among women visiting primary health care in Qatar. East Meditter Health J 17(11):855–861 Al-Meer FM, Aseel MT, Al-Khalaf J et al (2011) Knowledge, attitude and practices regarding cervical cancer and screening among women visiting primary health care in Qatar. East Meditter Health J 17(11):855–861
14.
Zurück zum Zitat Lee EE, Fogg L, Menon U (2008) Knowledge and beliefs related to cervical cancer and screening among Korean American women. West J Nurs Res 30(8):960–974CrossRefPubMedPubMedCentral Lee EE, Fogg L, Menon U (2008) Knowledge and beliefs related to cervical cancer and screening among Korean American women. West J Nurs Res 30(8):960–974CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Abiodun OA, Fatungase OK, Olu-Abiodun OO (2014) Knowledge, perception and predictors of uptake of cervical screening among rural Nigerian women. J Publ Health Epidem 6(3):119–124CrossRef Abiodun OA, Fatungase OK, Olu-Abiodun OO (2014) Knowledge, perception and predictors of uptake of cervical screening among rural Nigerian women. J Publ Health Epidem 6(3):119–124CrossRef
Metadaten
Titel
Cervical Cancer Knowledge, Perceptions and Screening Behaviour Among Female University Students in Ghana
verfasst von
Charity Binka
Samuel H Nyarko
David T Doku
Publikationsdatum
10.05.2015
Verlag
Springer US
Erschienen in
Journal of Cancer Education / Ausgabe 2/2016
Print ISSN: 0885-8195
Elektronische ISSN: 1543-0154
DOI
https://doi.org/10.1007/s13187-015-0852-x

Weitere Artikel der Ausgabe 2/2016

Journal of Cancer Education 2/2016 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.